Scancell Holdings (SCLP)
09/01/2018 - 07:00 RNS
RNS Number: 1654B Scancell Holdings Plc 09 January 2018 09 January 2018 Scancell Holdings Plc ("Scancell" or the "Company") Scancell to collaborate with BioNTech to investigate T cell receptor based therapeutics for the treatment of cancer Agreement expands potential therapeutic utility of Moditope to adoptive T cell therapy Scancell Holdings plc, ('Scancell' or th...
14/12/2017 - 08:07 StockMarketWire
Scancell, a developer of immunotherapies for the treatment of cancer, has partnered with the charity Cancer Research UK...
14/12/2017 - 07:00 RNS
RNS Number: 2811Z Scancell Holdings Plc 14 December 2017 14 December 2017 Scancell Holdings Plc ("Scancell" or the "Company") Scancell and Cancer Research UK collaborate to advance novel cancer immunotherapy into clinical trials Cancer Research UK to progress SCIB2 into a Phase 1/2 study for patients with a range of solid tumours Scancell Holdings PLC, a...
07/12/2017 - 23:16 Trends and Targets
FTSE FOR FRIDAY (FTSE:UKX) Sometimes, the utter boredom inflicted by the market leads one down a strange path. Th...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment